Antiviral decision ‘disappointing’: Tassone

Nicholas O’Donoghue 23/02/2024

Authorising pharmacists to prescribe Covid-19 antivirals could limit wastage, a Guild leader says The rejection of a recommendation to allow pharmacists to initiate Covid-19 oral antiviral treatment for patients eligible under the Pharmaceutical Benefits Scheme (PBS) is “disappointing”, Anthony Tassone, the president of the Pharmacy Guild of Australia’s Victorian branch believes. In a post

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Antiviral decision ‘disappointing’: Tassone

Previous ‘Pharmacy shops are just dead’

Next Government yet to confirm new 60-day list

MENU

ajp.com.au

Previous ‘Pharmacy shops are just dead’

Next Government yet to confirm new 60-day list

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.